These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27158877)

  • 21. [Early diagnosis and therapy of Alzheimer dementia. Careful documentation prevents degeneration].
    Kohler J; Riepe MW; Jendroska K; Pilartz H; Adler G; Berger FM; Calabrese P; Frölich L; Gertz HJ; Hampel H; Haupt M; Mielke R; Paulus HJ; Zedlick D
    MMW Fortschr Med; 2002 Nov; 144(47):53-4. PubMed ID: 12532523
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial.
    Callahan CM; Boustani MA; Unverzagt FW; Austrom MG; Damush TM; Perkins AJ; Fultz BA; Hui SL; Counsell SR; Hendrie HC
    JAMA; 2006 May; 295(18):2148-57. PubMed ID: 16684985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature.
    Nikisch G; Hertel A; Kiessling B; Wagner T; Krasz D; Hofmann E; Wiedemann G
    Eur J Med Res; 2008 Dec; 13(12):579-84. PubMed ID: 19073399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How does additional diagnostic testing influence the initial diagnosis in patients with cognitive complaints in a memory clinic setting?
    Meijs AP; Claassen JA; Rikkert MG; Schalk BW; Meulenbroek O; Kessels RP; Melis RJ
    Age Ageing; 2015 Jan; 44(1):72-7. PubMed ID: 24847028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic utility of 99mTc-HMPAO SPECT imaging: a retrospective case series from a tertiary referral early-onset cognitive disorders clinic.
    Swan A; Waddell B; Holloway G; Bak T; Colville S; Khan Z; Pal S
    Dement Geriatr Cogn Disord; 2015; 39(3-4):186-93. PubMed ID: 25572595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter population-based study on the prevalence of early onset dementia in Japan: vascular dementia as its prominent cause.
    Ikejima C; Ikeda M; Hashimoto M; Ogawa Y; Tanimukai S; Kashibayashi T; Miyanaga K; Yonemura K; Kakuma T; Murotani K; Asada T
    Psychiatry Clin Neurosci; 2014 Mar; 68(3):216-24. PubMed ID: 24372910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late life depression and dementia: a mental health literacy survey of Australian general practitioners.
    Wijeratne C; Harris P
    Int Psychogeriatr; 2009 Apr; 21(2):330-7. PubMed ID: 19138460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open referral policy within a nurse-led memory clinic: patient demographics, assessment scores, and diagnostic profiles.
    Minstrell M; Bentley M; Bucher H; Morrissey M; Higgs C; Robinson A; Stirling C
    Int Psychogeriatr; 2015 Jun; 27(6):967-79. PubMed ID: 25483359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.
    Gallucci M; Spagnolo P; Aricò M; Grossi E
    J Alzheimers Dis; 2016; 50(4):969-79. PubMed ID: 26836164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
    Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
    JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of dementia].
    Engedal K
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):520-4. PubMed ID: 11961983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do cholinesterase inhibitors act primarily on attention deficit? A naturalistic study in Alzheimer's disease patients.
    Bracco L; Bessi V; Padiglioni S; Marini S; Pepeu G
    J Alzheimers Dis; 2014; 40(3):737-42. PubMed ID: 24577458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dementia with Lewy Bodies and its differentiation from Alzheimer's disease].
    Ransmayr G; Katzenschlager R; Dal-Bianco P; Wenning G; Bancher C; Jellinger K; Schmidt R; Poewe W
    Neuropsychiatr; 2007; 21(2):63-74. PubMed ID: 17640492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and Prevalence of Early-Onset Dementia in Finland.
    Krüger J; Aaltonen M; Aho K; Heikkinen S; Kivisild A; Lehtonen A; Leppänen L; Rinnankoski I; Soppela H; Tervonen L; Suhonen NM; Haapasalo A; Portaankorva AM; Mäki-Petäjä-Leinonen A; Hartikainen P; Katisko K; Solje E
    Neurology; 2024 Aug; 103(4):e209654. PubMed ID: 39047214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry.
    Wimo A; Religa D; Spångberg K; Edlund AK; Winblad B; Eriksdotter M
    Int J Geriatr Psychiatry; 2013 Oct; 28(10):1039-44. PubMed ID: 23440702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of neuropsychological tests in the Cronos Project].
    Bianchi G; Gasparini M; Caffari B; Sorrentino GC; Bianchi C; Bruno G; Maggini M; Raschetti R; Vanacore N
    Ann Ist Super Sanita; 2005; 41(1):69-74. PubMed ID: 16037653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort.
    Behl P; Lanctôt KL; Streiner DL; Black SE
    Int Psychogeriatr; 2008 Dec; 20(6):1141-59. PubMed ID: 18606043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease.
    Nordström P; Religa D; Wimo A; Winblad B; Eriksdotter M
    Eur Heart J; 2013 Sep; 34(33):2585-91. PubMed ID: 23735859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.